Skip to main content
. 2022 May 2;22:143. doi: 10.1186/s12905-022-01726-w

Table 3.

Treatments of patients

Variables Patients (n = 152)
Treatments
Medication + surgery 80 (52.6%)
Medication 71 (46.7%)
Observation 1 (0.7%)
Medication
Single steroids 84 (55.6%)
Single tubercle bacillus drug 20 (13.2%)
Combined medication (Antibiotics and/or steroids and/or methotrexate and/or tubercle bacillus drug and/or immunosuppressants and/or bromocriptine) 47 (31.2%)
Surgery
Breast lesion excision by minimally invasive surgery 20 (13.2%)
Breast lesion excision by open surgery 60 (39.5%)
Without surgery 72 (47.4%)
Side effects
Skin rash 8 (5.3%)
Abnormal index of liver function 11 (7.2%)
Abnormal uric acid 3 (2.0%)
Edema on the lips and face 1 (0.7%)